Anti-OTOL1/ C1QTNF15/ C1QTNF16 functional antibody

Anti-OTOL1/ C1QTNF15/ C1QTNF16 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OTOL1/OTOL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0391-Ab-1/ GM-Tg-hg-SE0391-Ab-2Anti-Human OTOL1 monoclonal antibodyHuman
GM-Tg-rg-SE0391-Ab-1/ GM-Tg-rg-SE0391-Ab-2Anti-Rat OTOL1 monoclonal antibodyRat
GM-Tg-mg-SE0391-Ab-1/ GM-Tg-mg-SE0391-Ab-2Anti-Mouse OTOL1 monoclonal antibodyMouse
GM-Tg-cynog-SE0391-Ab-1/ GM-Tg-cynog-SE0391-Ab-2Anti-Cynomolgus/ Rhesus macaque OTOL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0391-Ab-1/ GM-Tg-felg-SE0391-Ab-2Anti-Feline OTOL1 monoclonal antibodyFeline
GM-Tg-cang-SE0391-Ab-1/ GM-Tg-cang-SE0391-Ab-2Anti-Canine OTOL1 monoclonal antibodyCanine
GM-Tg-bovg-SE0391-Ab-1/ GM-Tg-bovg-SE0391-Ab-2Anti-Bovine OTOL1 monoclonal antibodyBovine
GM-Tg-equg-SE0391-Ab-1/ GM-Tg-equg-SE0391-Ab-2Anti-Equine OTOL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0391-Ab-1/ GM-Tg-hg-SE0391-Ab-2; GM-Tg-rg-SE0391-Ab-1/ GM-Tg-rg-SE0391-Ab-2;
GM-Tg-mg-SE0391-Ab-1/ GM-Tg-mg-SE0391-Ab-2; GM-Tg-cynog-SE0391-Ab-1/ GM-Tg-cynog-SE0391-Ab-2;
GM-Tg-felg-SE0391-Ab-1/ GM-Tg-felg-SE0391-Ab-2; GM-Tg-cang-SE0391-Ab-1/ GM-Tg-cang-SE0391-Ab-2;
GM-Tg-bovg-SE0391-Ab-1/ GM-Tg-bovg-SE0391-Ab-2; GM-Tg-equg-SE0391-Ab-1/ GM-Tg-equg-SE0391-Ab-2
Products NameAnti-OTOL1 monoclonal antibody
Formatmab
Target NameOTOL1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OTOL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0391-Ag-1Recombinant multi-species OTOL1/ C1QTNF15/ C1QTNF16 protein


    Target information

    Target IDGM-SE0391
    Target NameOTOL1
    Gene ID131149,229389,295117,100426070,100855781,101091805,525044,100062344
    Gene Symbol and SynonymsC1QTNF15,C1QTNF16,Gm414,OTOL1,RGD1562064
    Uniprot AccessionA6NHN0
    Uniprot Entry NameOTOL1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182447
    Target ClassificationN/A

    The target: OTOL1, gene name: OTOL1, also named as C1QTNF15, C1QTNF16. This gene encodes a secreted glycoprotein with a C-terminal complement Cq1-like globular domain that belongs to the C1q/tumor necrosis factor-related protein (CTRP) family. The encoded protein is expressed in the inner ear and forms a multimeric complex called the otoconia, together with cerebellin-1 and otoconin-90, as part of the otoconial membrane. It contains extensive posttranslational modifications including hydroxylated prolines and glycosylated lysines. Naturally occurring mutations in this gene are associated with abnormal otoconia formation and balance deficits resulting from vestibular dysfunction. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.